Journal of Proteome Research (43) Vandewalle, C.; Van Roy, F.; Berx, G. The role of the ZEB family of transcription factors in development and disease. Cell. Mol. Life Sci. 2009, 66 (5), 773–87. (44) Sanchez-Tillo, E.; Lazaro, A.; Torrent, R.; Cuatrecasas, M.; Vaquero, E. C.; Castells, A.; Engel, P.; Postigo, A. ZEB1 represses E-cadherin and induces an EMT by recruiting the SWI/SNF chromatin- remodeling protein BRG1. Oncogene 2010, 29 (24), 3490–500. (45) Krupnik, V. E.; Sharp, J. D.; Jiang, C.; Robison, K.; Chickering, T. W.; Amaravadi, L.; Brown, D. E.; Guyot, D.; Mays, G.; Leiby, K.; Chang, B.; Duong, T.; Goodearl, A. D.; Gearing, D. P.; Sokol, S. Y.; McCarthy, S. A. Functional and structural diversity of the human Dickkopf gene family. Gene 1999, 238 (2), 301–13. (46) Niehrs, C. Function and biological roles of the Dickkopf family of Wnt modulators. Oncogene 2006, 25 (57), 7469–81. (47) Baehs, S.; Herbst, A.; Thieme, S. E.; Perschl, C.; Behrens, A.; Scheel, S.; Jung, A.; Brabletz, T.; Goke, B.; Blum, H.; Kolligs, F. T. Dickkopf-4 is frequently down-regulated and inhibits growth of colorec- tal cancer cells. Cancer Lett. 2009, 276 (2), 152–9. (48) Matsuzawa, S. I.; Reed, J. C.; Siah-1, S. I. P. and Ebi collaborate in a novel pathway for beta-catenin degradation linked to p53 responses. Mol. Cell 2001, 7 (5), 915–26. (49) Chen, X.; Mo, P.; Li, X.; Zheng, P.; Zhao, L.; Xue, Z.; Ren, G.; Han, G.; Wang, X.; Fan, D. CacyBP/SIP protein promotes proliferation and G1/S transition of human pancreatic cancer cells. Mol. Carcinog. 2011, 50 (10), 804–10. (50) Wang, L.; Wang, J.; Sun, S.; Rodriguez, M.; Yue, P.; Jang, S. J.; Mao, L. A novel DNMT3B subfamily, DeltaDNMT3B, is the predomi- nant form of DNMT3B in non-small cell lung cancer. Int. J. Oncol. 2006, 29 (1), 201–7. (51) DiFeo, A.; Feld, L.; Rodriguez, E.; Wang, C.; Beer, D. G.; Martignetti, J. A.; Narla, G. A functional role for KLF6-SV1 in lung adenocarcinoma prognosis and chemotherapy response. Cancer Res. 2008, 68 (4), 965–70. (52) Chen, X.; Truong, T. T.; Weaver, J.; Bove, B. A.; Cattie, K.; Armstrong, B. A.; Daly, M. B.; Godwin, A. K. Intronic alterations in BRCA1 and BRCA2: eﬀect on mRNA splicing ﬁdelity and expression. Hum. Mutat. 2006, 27 (5), 427–35. (53) Fackenthal, J. D.; Godley, L. A. Aberrant RNA splicing and its functional consequences in cancer cells. Dis. Model Mech. 2008, 1 (1), 37–42. (54) Long, J. C.; Caceres, J. F. The SR protein family of splicing factors: master regulators of gene expression. Biochem. J. 2009, 417 (1), 15–27. (55) Sahai, E.; Marshall, C. J. RHO-GTPases and cancer. Nat. Rev. Cancer 2002, 2 (2), 133–42. (56) Bardelli, A.; Saha, S.; Sager, J. A.; Romans, K. E.; Xin, B.; Markowitz, S. D.; Lengauer, C.; Velculescu, V. E.; Kinzler, K. W.; Vogelstein, B. PRL-3 expression in metastatic cancers. Clin. Cancer Res. 2003, 9 (15), 5607–15. (57) Winter-Vann, A. M.; Baron, R. A.; Wong, W.; dela Cruz, J.; York, J. D.; Gooden, D. M.; Bergo, M. O.; Young, S. G.; Toone, E. J.; Casey, P. J. A small-molecule inhibitor of isoprenylcysteine carboxyl methyltransferase with antitumor activity in cancer cells. Proc. Natl. Acad. Sci. U.S.A. 2005, 102 (12), 4336–41. (58) Jang, G. F.; Gelb, M. H. Substrate speciﬁcity of mammalian prenyl protein-speciﬁc endoprotease activity. Biochemistry 1998, 37 (13), 4473–81. (59) Sever, N.; Song, B. L.; Yabe, D.; Goldstein, J. L.; Brown, M. S.; DeBose-Boyd, R. A. Insig-dependent ubiquitination and degradation of mammalian 3-hydroxy-3-methylglutaryl-CoA reductase stimulated by sterols and geranylgeraniol. J. Biol. Chem. 2003, 278 (52), 52479–90. ARTICLE 1195 dx.doi.org/10.1021/pr2009109 |J. Proteome Res. 2012, 11, 1184–1195